Harvard Apparatus Regenerative Technology Operating Income 2013-2024 | HRGN

Harvard Apparatus Regenerative Technology operating income from 2013 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Harvard Apparatus Regenerative Technology Operating Income 2013-2024 | HRGN

Harvard Apparatus Regenerative Technology operating income from 2013 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$126B
Cencora (COR)$46.2B
ICON (ICLR)$24.1B
DiDi Global (DIDIY)$18.8B
Avantor (AVTR)$18.3B
Natera (NTRA)$15.7B
Revvity (RVTY)$15.1B
Viatris (VTRS)$14.1B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.5B
Medpace Holdings (MEDP)$11B
Charles River Laboratories (CRL)$10.6B
Sonic Healthcare (SKHHY)$8.9B
Doximity (DOCS)$7.5B
HealthEquity (HQY)$6.9B
Bausch + Lomb (BLCO)$6.5B
PACS (PACS)$6.2B
Organon (OGN)$5.3B
Life Times (LTH)$4.9B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4B
Concentras Parent (CON)$2.9B
GoodRx Holdings (GDRX)$2.9B
BrightSpring Health Services (BTSG)$2.5B
Ardent Health Partners (ARDT)$2.5B
Progyny (PGNY)$2.2B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2.1B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.8B